Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy

Achanta, 2001, Interaction of p53 and DNA- PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage, Cancer Res, 61, 8723 Parker, 2009, Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer, Chem Rev, 109, 2880, 10.1021/cr900028p Senanayake, 2011, Novel anticancer polymeric conjugates of activated nucleoside analogues, Bioconjug Chem, 22, 1983, 10.1021/bc200173e van Moorsel, 1997, Gemcitabine: future prospects of single-agent and combination studies, Oncologist, 2, 127, 10.1634/theoncologist.2-3-127 Hung, 2012, Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge, Cancer Lett, 320, 138, 10.1016/j.canlet.2012.03.007 Allain, 2012, Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices, Nucleic Acids Res, 40, 1891, 10.1093/nar/gkr681 Rejiba, 2011, Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer, Nanomedicine, 7, 841, 10.1016/j.nano.2011.02.012 Li, 2010, Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery, J Control Release, 142, 416, 10.1016/j.jconrel.2009.11.008 Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res, 46, 6387 Li, 2009, Nanoparticles evading the reticuloendothelial system: role of the supported bilayer, Biochim Biophys Acta, 1788, 2259, 10.1016/j.bbamem.2009.06.022 Banerjee, 2004, Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells, Int J Cancer, 112, 693, 10.1002/ijc.20452 Li, 2012, Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor, J Control Release, 158, 108, 10.1016/j.jconrel.2011.10.020 Zhang, 2011, Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells, Pharm Res, 28, 1167, 10.1007/s11095-011-0381-1 Risbood, 2008, Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) salt, Bioorg Med Chem Lett, 18, 2957, 10.1016/j.bmcl.2008.03.063 Karl, 1980, Effects of alkaline phosphatase activity on nucleotide measurements in aquatic microbial communities, Appl Environ Microbiol, 40, 549, 10.1128/AEM.40.3.549-561.1980 Kim, 2009, Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice, J Control Release, 140, 55, 10.1016/j.jconrel.2009.07.005 Johnson, 2000, Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies, Clin Pharmacokinet, 39, 5, 10.2165/00003088-200039010-00002 Cohen, 1997, Caspases: the executioners of apoptosis, Biochem J, 326, 1, 10.1042/bj3260001 Arya, 2011, Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy, Nanomedicine, 7, 859, 10.1016/j.nano.2011.03.009 Tang, 2012, EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer, PLoS One, 7, e31067, 10.1371/journal.pone.0031067 Andreeva, 2001, Evaluation of cell proliferation in human atherosclerotic lesions, Methods Mol Med, 52, 213 Hornick, 2012, Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands, Surgery, 152, S152, 10.1016/j.surg.2012.05.014 Riganas, 2012, Synthesis, sigma(1), sigma(2)-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes, Bioorg Med Chem, 20, 3323, 10.1016/j.bmc.2012.03.038 Everaert, 1997, Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer, Anticancer Res, 17, 1577 White, 1987, Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells, J Clin Invest, 79, 380, 10.1172/JCI112823 Brusa, 2007, Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs, Anticancer Res, 27, 195 Immordino, 2004, Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs, J Control Release, 100, 331, 10.1016/j.jconrel.2004.09.001 Lansakara, 2012, Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles, Int J Pharm, 429, 123, 10.1016/j.ijpharm.2012.03.014 Sarpietro, 2011, Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers, Int J Pharm, 406, 69, 10.1016/j.ijpharm.2010.12.038 Li, 2010, Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system, Eur J Pharm Sci, 41, 498, 10.1016/j.ejps.2010.08.004 Meier, 2006, Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules, Antiviral Res, 71, 282, 10.1016/j.antiviral.2006.04.011 Zhang, 2012, In vivo gene delivery by nonviral vectors: overcoming hurdles?, Mol Ther, 20, 1298, 10.1038/mt.2012.79 Xu, 1996, Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection, Biochemistry, 35, 5616, 10.1021/bi9602019